Artículos por temáticas

Longitudinal volume changes of hippocampal subfields and cognitive decline in Parkinson's disease

Xu R, Hu X, Jiang X, Zhang Y, Wang J, Zeng X.

Quant Imaging Med Surg. 2020 Jan;10(1):220-232. doi: 10.21037/qims.2019.10.17.

Dysbiosis in Parkinson's disease might be triggered by certain antibiotics

Ternák G, Kuti D, Kovács KJ.

Med Hypotheses. 2020 Apr;137:109564. doi: 10.1016/j.mehy.2020.109564. Epub 2020 Jan 9.

Therapeutic effects of forced exercise cycling in individuals with Parkinson's disease

Miner DG, Aron A, DiSalvo E.

J Neurol Sci. 2020 Mar 15;410:116677. doi: 10.1016/j.jns.2020.116677. Epub 2020 Jan 9.

Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene

Azevedo C, Chumarina M, Serafimova E, Goldwurm S, Collin A, Roybon L, Savchenko E, Pomeshchik Y.

Stem Cell Res. 2020 Mar;43:101694. doi: 10.1016/j.scr.2019.101694. Epub 2020 Jan 11.

Parkinsonism and Bipolar Disorder

Dols A, Lemstra AW.

Bipolar Disord. 2020 Jun;22(4):413-415. doi: 10.1111/bdi.12888. Epub 2020 Jan 30.

Increased level of NEAT1 long non-coding RNA is detectable in peripheral blood cells of patients with Parkinson's disease

Boros FA, Maszlag-Török R, Vécsei L, Klivényi P.

Brain Res. 2020 Mar 1;1730:146672. doi: 10.1016/j.brainres.2020.146672. Epub 2020 Jan 14.

The effects of dual-task in patients with Parkinson's disease performing cognitive-motor paradigms

Hsiu-Chen C, Chiung-Chu C, Jiunn-Woei L, Wei-Da C, Yi-Hsin W, Ya-Ju C, Chin-Song L.

J Clin Neurosci. 2020 Feb;72:72-78. doi: 10.1016/j.jocn.2020.01.024. Epub 2020 Jan 14.

Voice changes in Parkinson's disease: What are they telling us?

Ma A, Lau KK, Thyagarajan D.

J Clin Neurosci. 2020 Feb;72:1-7. doi: 10.1016/j.jocn.2019.12.029. Epub 2020 Jan 14.

Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms

Santaella A, Kuiperij HB, van Rumund A, Esselink RAJ, van Gool AJ, Bloem BR, Verbeek MM.

BMC Neurol. 2020 Jan 17;20(1):26. doi: 10.1186/s12883-020-1608-8.

A case report of adult-onset Alexander disease clinically presenting as Parkinson's disease: is the comorbidity associated with genetic susceptibility?

Park J, Park ST, Kim J, Kwon KY.

BMC Neurol. 2020 Jan 17;20(1):27. doi: 10.1186/s12883-020-1616-8.

Impaired option generation underpins deficient reasoning in Parkinson's disease patients with apathy

Mole JA, Josephs L, Prangnell SJ.

Appl Neuropsychol Adult. 2020 Jan 17:1-6. doi: 10.1080/23279095.2020.1712400. Online ahead of print.

Improvements of Motor Performances in the Drosophila LRRK2 Loss-of-Function Model of Parkinson's Disease: Effects of Dialyzed Leucocyte Extracts from Human Serum

Diana A, Collu M, Casu MA, Mocci I, Aguilar-Santelises M, Setzu MD.

Brain Sci. 2020 Jan 14;10(1):45. doi: 10.3390/brainsci10010045.

Rapid picture naming in Parkinson's disease using the Mobile Universal Lexicon Evaluation System (MULES)

Conway J, Ilardi M, Gonzalez C, Dahan N, Fallon S, Moehringer N, Hasanaj L, Joseph B, Serrano L, Rizzo JR, Rucker JC, Feigin A, Frucht S, Galetta SL, Balcer LJ.

J Neurol Sci. 2020 Mar 15;410:116680. doi: 10.1016/j.jns.2020.116680. Epub 2020 Jan 9.

Ultrasonic stimulation of the brain to enhance the release of dopamine - A potential novel treatment for Parkinson's disease

Xu T, Lu X, Peng D, Wang G, Chen C, Liu W, Wu W, Mason TJ.

Ultrason Sonochem. 2020 May;63:104955. doi: 10.1016/j.ultsonch.2019.104955. Epub 2019 Dec 31.

The highly selective mGlu(2) receptor positive allosteric modulator LY-487,379 alleviates l-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease

Hamadjida A, Sid-Otmane L, Kwan C, Frouni I, Nafade V, Bédard D, Gagnon D, Wallman MJ, Rouillard C, Parent A, Parent M, Huot P.

Eur J Neurosci. 2020 Jun;51(12):2412-2422. doi: 10.1111/ejn.14679. Epub 2020 Feb 12.